Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Are you looking for a new and exciting career opportunity? The Oxford-GSK IMCM are seeking a Senior Bioinformatician, to join the team! The initial focus of the IMCM is on neurodegeneration and the
-
neurodegenerative diseases, reporting to the Oxford-GSK IMCM co-director Professor John Todd and Dr Anna Sher, Director in Quantitative Systems Pharmacology at GSK, and with oversight from the Oxford-GSK IMCM
-
Are you looking for a new and exciting career opportunity? The Oxford-GSK IMCM are seeking a Senior Bioinformatician, to join the team! The initial focus of the IMCM is on neurodegeneration and the
-
. value assessment of pharmaceuticals The Fellow will spend four days per week at GSK working in the GSK's U.S. Value Evidence and Outcomes Research Group near Philadelphia. One day per week will be spent
-
Position Details Position Information Recruitment/Posting Title Post Doctorial Associate (U.S. GSK/Rutgers HOPE) Department Pharm-Pharmacy Practice&Admin Salary Commensurate With Experience Posting
-
of pharmaceuticals The Fellow will spend four days per week at GlaxoSmithKline (GSK) working in the Global Value Evidence and Outcomes Research Group group near Philadelphia. One day per week will be spent at Rutgers
-
Are you ready to be part of ground-breaking research at the forefront of molecular neurodegeneration? The newly established Oxford-GSK Institute for Molecular & Computational Medicine (IMCM) is
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 24 hours ago
development, program facilitation, and program assessment for Morehead programs such as summer camp programs, Scout programs, GSK Fulldome Theater, Science Stage, and traveling programs such as Morehead in
-
We are seeking a highly motivated Postdoctoral Scientist to join the Fowler group, led by Oxford-GSK IMCM Fellow Dr. Fowler. The Fowler Lab focuses on molecular neurodegeneration and is committed
-
, hosted by the Butantan Institute in São Paulo (Brazil) and funded by the São Paulo Research Foundation (FAPESP) through its Engineering Research Centers (ERCs) program in partnership with GSK. CENTD is